[go: up one dir, main page]

TR200003158T2 - Jelleşebilen farmasötik bileşimler - Google Patents

Jelleşebilen farmasötik bileşimler

Info

Publication number
TR200003158T2
TR200003158T2 TR2000/03158T TR200003158T TR200003158T2 TR 200003158 T2 TR200003158 T2 TR 200003158T2 TR 2000/03158 T TR2000/03158 T TR 2000/03158T TR 200003158 T TR200003158 T TR 200003158T TR 200003158 T2 TR200003158 T2 TR 200003158T2
Authority
TR
Turkey
Prior art keywords
pharmaceutical compositions
relates
weight
level
gelling pharmaceutical
Prior art date
Application number
TR2000/03158T
Other languages
English (en)
Inventor
Fanara Domenico
Vranckx Henry
Deleers Michel
Original Assignee
Ucb, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb, S.A. filed Critical Ucb, S.A.
Publication of TR200003158T2 publication Critical patent/TR200003158T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Anesthesiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Bulus, en azindan bir aktif maddenin kontrollü bir sekilde salinmasi için asagidakileri içeren, akiskan farmasötik bilesimlere iliskindir: a) terapötik olarak etkili bir miktarda en azindan bir aktif madde; b) agirlikça %3-55 seviyesinde fosfolipid; c) agirlikça %16-72 seviyesinde farmasötik olarak kabul edilebilir bir veya birkaç çözücü; ve d) agirlikça %4-52 seviyesinde en azindan bir yagli asit. Bahsedilen bilesimin özelligi, sulu bir faz mevcudiyetinde aninda jellesebilmesidir. Bulus, ayrica bahsedilen bilesimlerin hazirlanmasi için yöntemlere ve bunlarin, bir insanin veya hayvanin tedavisinde kullanmasina da iliskindir.
TR2000/03158T 1998-04-30 1999-04-16 Jelleşebilen farmasötik bileşimler TR200003158T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE9800329A BE1011899A6 (fr) 1998-04-30 1998-04-30 Compositions pharmaceutiques gelifiables utilisables.

Publications (1)

Publication Number Publication Date
TR200003158T2 true TR200003158T2 (tr) 2001-03-21

Family

ID=3891230

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03158T TR200003158T2 (tr) 1998-04-30 1999-04-16 Jelleşebilen farmasötik bileşimler

Country Status (25)

Country Link
US (3) US6464987B1 (tr)
EP (2) EP1073414B1 (tr)
JP (2) JP2002513748A (tr)
KR (1) KR100567975B1 (tr)
CN (1) CN1183901C (tr)
AT (2) ATE307569T1 (tr)
AU (2) AU738455B2 (tr)
BE (1) BE1011899A6 (tr)
BG (1) BG64723B1 (tr)
BR (1) BR9910066A (tr)
CA (1) CA2330500C (tr)
DE (2) DE69927963T2 (tr)
DK (1) DK1073415T3 (tr)
EA (1) EA002530B1 (tr)
ES (2) ES2249891T3 (tr)
HU (1) HU226556B1 (tr)
ID (1) ID26221A (tr)
IL (1) IL139113A0 (tr)
IS (1) IS2354B (tr)
NO (1) NO20005431L (tr)
NZ (1) NZ507707A (tr)
RS (1) RS50025B (tr)
TR (1) TR200003158T2 (tr)
WO (2) WO1999056725A1 (tr)
ZA (1) ZA200005915B (tr)

Families Citing this family (159)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1011899A6 (fr) * 1998-04-30 2000-02-01 Ucb Sa Compositions pharmaceutiques gelifiables utilisables.
AU759641B2 (en) 1998-08-19 2003-04-17 Skyepharma Canada Inc. Injectable aqueous dispersions of propofol
US11026768B2 (en) 1998-10-08 2021-06-08 Align Technology, Inc. Dental appliance reinforcement
DE10024413A1 (de) * 2000-05-19 2001-12-06 Mika Pharma Gmbh Pharmazeutische und/oder kosmetische Zubereitung
DE10057769A1 (de) 2000-11-22 2002-05-23 Beiersdorf Ag Haarpflegeprodukte mit einem Gehalt an dispersen Flüssigkristallen, welche kubische Phasen darstellen
AU2002335077B2 (en) * 2001-10-19 2006-09-07 Idexx Laboratories, Inc. Injectable compositions for the controlled delivery of pharmacologically active compound
US6946137B2 (en) * 2001-10-19 2005-09-20 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
AU2003227827B2 (en) * 2002-03-12 2008-09-25 Ethypharm Composition having gelling properties for the prolonged delivery of bioactive substances
FR2837099B1 (fr) * 2002-03-12 2005-03-18 Ethypharm Sa Composition a proprietes gelifiantes destinee a la delivrance prolongee de substances bio-actives
US20040018237A1 (en) 2002-05-31 2004-01-29 Perricone Nicholas V. Topical drug delivery using phosphatidylcholine
US8435942B2 (en) * 2002-05-31 2013-05-07 Transdermal Biotechnology, Inc. Methods for formulating stabilized insulin compositions
US20050031650A1 (en) * 2002-08-26 2005-02-10 Ethypharm Composition with gelling properties for the sustained delivery of bioactive substances
DE10255195A1 (de) * 2002-11-27 2004-06-09 Lipoid Gmbh Micellare wasserlösliche Konzentrate
DK1682091T3 (en) * 2003-11-07 2017-05-15 Camurus Ab COMPOSITIONS OF LIPIDS AND CATIONIC PEPTIDES
US20070232695A1 (en) * 2004-01-28 2007-10-04 Collegium Pharmaceutical, Inc. Gelled Periodontal Anesthetic Preparation
US9492245B2 (en) 2004-02-27 2016-11-15 Align Technology, Inc. Method and system for providing dynamic orthodontic assessment and treatment profiles
RU2288699C2 (ru) * 2004-03-23 2006-12-10 Дж. Б. Кемикалс Энд Фармасьютикалс Лимитед Гелевая композиция для лечения стоматологических заболеваний и способ ее получения
MXPA06014095A (es) * 2004-06-04 2007-08-07 Camurus Ab Formulaciones de deposito de lipidos.
GB0412530D0 (en) * 2004-06-04 2004-07-07 Camurus Ab Formulation
US7858115B2 (en) * 2004-06-24 2010-12-28 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
AU2005302554A1 (en) * 2004-10-28 2006-05-11 Idexx Laboratories, Inc. Compositions for controlled delivery of pharmaceutically active compounds
US20060115782A1 (en) * 2004-11-30 2006-06-01 Chunhua Li Systems and methods for coating a dental appliance
US20060115785A1 (en) 2004-11-30 2006-06-01 Chunhua Li Systems and methods for intra-oral drug delivery
US20060127437A1 (en) * 2004-12-13 2006-06-15 Misty Anderson Kennedy Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
EP1848403B8 (en) * 2005-01-14 2010-05-19 Camurus Ab Topical bioadhesive formulations
US9649382B2 (en) * 2005-01-14 2017-05-16 Camurus Ab Topical bioadhesive formulations
JP5171262B2 (ja) * 2005-01-14 2013-03-27 カムルス エービー ソマトスタチン類似体製剤
ATE462409T1 (de) * 2005-01-14 2010-04-15 Camurus Ab Topische bioadhäsive formulierungen
ATE501710T1 (de) * 2005-01-14 2011-04-15 Camurus Ab Somatostatin-analog-formulierungen
CA2595385C (en) 2005-01-21 2011-01-25 Camurus Ab Pharmaceutical lipid compositions
CA2609810C (en) * 2005-06-06 2012-05-22 Camurus Ab Glp-1 analogue formulations
SE531318C2 (sv) * 2007-02-22 2009-02-24 Tigran Technologies Ab Publ Injicerbar suspension innefattande titan-,titanlegerings- eller titanoxidpartiklar av mikrostruktur
US7878805B2 (en) 2007-05-25 2011-02-01 Align Technology, Inc. Tabbed dental appliance
GB0711656D0 (en) 2007-06-15 2007-07-25 Camurus Ab Formulations
GB0716385D0 (en) 2007-08-22 2007-10-03 Camurus Ab Formulations
ES2582635T3 (es) * 2007-09-12 2016-09-14 Galderma Research & Development Utilización de excipientes como conservantes y composiciones farmacéuticas que los contienen
US8738394B2 (en) 2007-11-08 2014-05-27 Eric E. Kuo Clinical data file
FR2926996B1 (fr) 2008-01-31 2013-06-21 Ethypharm Sa Composition pharmaceutique a proprietes gelifiantes contenant un derive de tyrosine
US8108189B2 (en) 2008-03-25 2012-01-31 Align Technologies, Inc. Reconstruction of non-visible part of tooth
US9492243B2 (en) 2008-05-23 2016-11-15 Align Technology, Inc. Dental implant positioning
US8092215B2 (en) 2008-05-23 2012-01-10 Align Technology, Inc. Smile designer
US8172569B2 (en) 2008-06-12 2012-05-08 Align Technology, Inc. Dental appliance
GB0815435D0 (en) 2008-08-22 2008-10-01 Camurus Ab Formulations
US20110229565A1 (en) 2008-09-17 2011-09-22 Karp Jeffrey M Drug Delivery Composition Comprising a Self-Assembled Gelator
US8152518B2 (en) 2008-10-08 2012-04-10 Align Technology, Inc. Dental positioning appliance having metallic portion
US8292617B2 (en) 2009-03-19 2012-10-23 Align Technology, Inc. Dental wire attachment
US8728516B2 (en) * 2009-04-30 2014-05-20 Abbvie Inc. Stabilized lipid formulation of apoptosis promoter
US20100278921A1 (en) * 2009-04-30 2010-11-04 Fischer Cristina M Solid oral formulation of abt-263
US8362013B2 (en) * 2009-04-30 2013-01-29 Abbvie Inc. Salt of ABT-263 and solid-state forms thereof
US20100297194A1 (en) * 2009-04-30 2010-11-25 Nathaniel Catron Formulation for oral administration of apoptosis promoter
US20100280031A1 (en) * 2009-04-30 2010-11-04 Paul David Lipid formulation of apoptosis promoter
TWI532484B (zh) * 2009-06-08 2016-05-11 艾伯維有限公司 包含凋亡促進劑之固態分散劑
TWI471321B (zh) * 2009-06-08 2015-02-01 亞培公司 Ｂｃｌ－２族群抑制劑之口服醫藥劑型
DE102010027315A1 (de) 2009-07-24 2011-01-27 Mika Pharma Gesellschaft Für Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh Verfahren zur Entwicklung einer als Schaum auf die Haut zu applizierende flüssige Zusammensetzung sowie eine topisch applizierbare Zusammensetzung
US8765031B2 (en) 2009-08-13 2014-07-01 Align Technology, Inc. Method of forming a dental appliance
US8927009B2 (en) * 2009-12-22 2015-01-06 Abbvie Inc. ABT-263 capsule
CA2792003A1 (en) * 2010-03-02 2011-09-09 Imagenetix, Inc. Compositions comprising myristic acid and uses thereof
US9241774B2 (en) 2010-04-30 2016-01-26 Align Technology, Inc. Patterned dental positioning appliance
US9211166B2 (en) 2010-04-30 2015-12-15 Align Technology, Inc. Individualized orthodontic treatment index
WO2012040623A2 (en) 2010-09-24 2012-03-29 The Brigham And Women's Hospital, Inc. Nanostructured gels capable of controlled release of encapsulated agents
UA113500C2 (xx) 2010-10-29 2017-02-10 Одержані екструзією розплаву тверді дисперсії, що містять індукуючий апоптоз засіб
WO2012125214A1 (en) 2011-03-17 2012-09-20 Transdermal Biotechnology, Inc. Topical nitric oxide systems and methods of use thereof
WO2012144943A1 (en) * 2011-04-18 2012-10-26 Lipidor Ab Liquid carrier for oral delivery of a pharmacologically active agent
US9403238B2 (en) 2011-09-21 2016-08-02 Align Technology, Inc. Laser cutting
US8716363B2 (en) * 2011-09-28 2014-05-06 Globus Medical, Inc. Biodegradable putty compositions and implant devices, methods, and kits relating to the same
CN104093399B (zh) * 2011-12-05 2018-03-13 卡穆鲁斯公司 鲁棒性控释肽制剂
CN104302188A (zh) * 2011-12-21 2015-01-21 希尔氏宠物营养品公司 使用抗坏血酸酯治疗或减轻牙科病症
US9375300B2 (en) 2012-02-02 2016-06-28 Align Technology, Inc. Identifying forces on a tooth
US9220580B2 (en) 2012-03-01 2015-12-29 Align Technology, Inc. Determining a dental treatment difficulty
CA2871821C (en) 2012-05-10 2021-01-12 Painreform Ltd. Depot formulations of a local anesthetic and methods for preparation thereof
US9414897B2 (en) 2012-05-22 2016-08-16 Align Technology, Inc. Adjustment of tooth position in a virtual dental model
IN2014DN09831A (tr) 2012-05-25 2015-08-07 Camurus Ab
PL2877155T3 (pl) 2012-07-26 2021-05-17 Camurus Ab Formulacje opioidowe
EA034855B1 (ru) 2012-07-26 2020-03-30 Камурус Аб Предшественник депо-препарата, содержащий бупренорфин, и способ лечения путем его введения
US8871259B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US8871262B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US8871255B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US8871254B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US8871256B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US8871258B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US8871261B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
US8871257B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871260B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9393264B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US10449016B2 (en) 2014-09-19 2019-10-22 Align Technology, Inc. Arch adjustment appliance
US9610141B2 (en) 2014-09-19 2017-04-04 Align Technology, Inc. Arch expanding appliance
US9744001B2 (en) 2014-11-13 2017-08-29 Align Technology, Inc. Dental appliance with cavity for an unerupted or erupting tooth
US10504386B2 (en) 2015-01-27 2019-12-10 Align Technology, Inc. Training method and system for oral-cavity-imaging-and-modeling equipment
US9610242B2 (en) * 2015-08-18 2017-04-04 Concept Labs, Inc. Water-gel emulsion compositions and methods
EP3359128A1 (en) * 2015-10-08 2018-08-15 The Brigham and Women's Hospital, Inc. Stabilized assembled nanostructures for delivery of encapsulated agents
US11554000B2 (en) 2015-11-12 2023-01-17 Align Technology, Inc. Dental attachment formation structure
US11931222B2 (en) 2015-11-12 2024-03-19 Align Technology, Inc. Dental attachment formation structures
US11596502B2 (en) 2015-12-09 2023-03-07 Align Technology, Inc. Dental attachment placement structure
US11103330B2 (en) 2015-12-09 2021-08-31 Align Technology, Inc. Dental attachment placement structure
WO2017193139A1 (en) 2016-05-06 2017-11-09 The Brigham And Women's Hospital, Inc. Binary self assembled gels for controlled delivery of encapsulated agents to cartilage
US10470847B2 (en) 2016-06-17 2019-11-12 Align Technology, Inc. Intraoral appliances with sensing
EP3471653B1 (en) 2016-06-17 2021-12-22 Align Technology, Inc. Orthodontic appliance performance monitor
CN210727927U (zh) 2016-07-27 2020-06-12 阿莱恩技术有限公司 口内扫描系统
CN117257492A (zh) 2016-11-04 2023-12-22 阿莱恩技术有限公司 用于牙齿图像的方法和装置
WO2018102702A1 (en) 2016-12-02 2018-06-07 Align Technology, Inc. Dental appliance features for speech enhancement
EP3547950A1 (en) 2016-12-02 2019-10-09 Align Technology, Inc. Methods and apparatuses for customizing rapid palatal expanders using digital models
US11376101B2 (en) 2016-12-02 2022-07-05 Align Technology, Inc. Force control, stop mechanism, regulating structure of removable arch adjustment appliance
CN119925011A (zh) 2016-12-02 2025-05-06 阿莱恩技术有限公司 腭扩张器和扩张腭的方法
US10548700B2 (en) 2016-12-16 2020-02-04 Align Technology, Inc. Dental appliance etch template
US11020410B2 (en) 2017-02-03 2021-06-01 The Brigham And Women's Hospital, Inc. Self-assembled gels formed with anti-retroviral drugs, prodrugs thereof, and pharmaceutical uses thereof
US10779718B2 (en) 2017-02-13 2020-09-22 Align Technology, Inc. Cheek retractor and mobile device holder
WO2018183358A1 (en) 2017-03-27 2018-10-04 Align Technology, Inc. Apparatuses and methods assisting in dental therapies
US10613515B2 (en) 2017-03-31 2020-04-07 Align Technology, Inc. Orthodontic appliances including at least partially un-erupted teeth and method of forming them
CA3061480A1 (en) 2017-05-08 2018-11-15 Alivio Therapeutics, Inc. Formulation of nanostructured gels for increased agent loading and adhesion
US11045283B2 (en) 2017-06-09 2021-06-29 Align Technology, Inc. Palatal expander with skeletal anchorage devices
CN110769777B (zh) 2017-06-16 2023-08-11 阿莱恩技术有限公司 牙齿类型和萌出状态的自动检测
WO2019005808A1 (en) 2017-06-26 2019-01-03 Align Technology, Inc. BIOCAPTOR PERFORMANCE INDICATOR FOR INTRABUCCAL DEVICES
US10885521B2 (en) 2017-07-17 2021-01-05 Align Technology, Inc. Method and apparatuses for interactive ordering of dental aligners
CN111107806B (zh) 2017-07-21 2022-04-19 阿莱恩技术有限公司 颚轮廓锚固
EP4278957A3 (en) 2017-07-27 2024-01-24 Align Technology, Inc. System and methods for processing an orthodontic aligner by means of an optical coherence tomography
CN110996842B (zh) 2017-07-27 2022-10-14 阿莱恩技术有限公司 牙齿着色、透明度和上釉
US12274597B2 (en) * 2017-08-11 2025-04-15 Align Technology, Inc. Dental attachment template tray systems
WO2019035979A1 (en) 2017-08-15 2019-02-21 Align Technology, Inc. EVALUATION AND CALCULATION OF BUCCAL CORRIDOR
US11123156B2 (en) 2017-08-17 2021-09-21 Align Technology, Inc. Dental appliance compliance monitoring
WO2019071019A1 (en) 2017-10-04 2019-04-11 Align Technology, Inc. INTRAORAL APPARATUS FOR SAMPLING MOUTH TISSUE
US10813720B2 (en) 2017-10-05 2020-10-27 Align Technology, Inc. Interproximal reduction templates
CN114939001B (zh) 2017-10-27 2025-02-18 阿莱恩技术有限公司 替代咬合调整结构
US11576752B2 (en) 2017-10-31 2023-02-14 Align Technology, Inc. Dental appliance having selective occlusal loading and controlled intercuspation
CN111315315B (zh) 2017-11-01 2022-08-23 阿莱恩技术有限公司 自动治疗规划
US11534974B2 (en) 2017-11-17 2022-12-27 Align Technology, Inc. Customized fabrication of orthodontic retainers based on patient anatomy
US11219506B2 (en) 2017-11-30 2022-01-11 Align Technology, Inc. Sensors for monitoring oral appliances
US11432908B2 (en) 2017-12-15 2022-09-06 Align Technology, Inc. Closed loop adaptive orthodontic treatment methods and apparatuses
US10980613B2 (en) 2017-12-29 2021-04-20 Align Technology, Inc. Augmented reality enhancements for dental practitioners
CN114587237B (zh) 2018-01-26 2025-09-30 阿莱恩技术有限公司 诊断性口内扫描和追踪
US11937991B2 (en) 2018-03-27 2024-03-26 Align Technology, Inc. Dental attachment placement structure
CN108498376B (zh) * 2018-04-02 2020-11-13 榛硕（武汉）智能科技有限公司 一种甲基硅油乳液及其制备方法
US11564777B2 (en) 2018-04-11 2023-01-31 Align Technology, Inc. Releasable palatal expanders
US11839605B2 (en) 2018-10-11 2023-12-12 Alivio Therapeutics, Inc. Non-injectable hydrogel formulations for smart release
EP3860569A1 (en) 2018-10-15 2021-08-11 Cipla Limited Pharmaceutical formulation
EP3848016A1 (en) * 2020-01-08 2021-07-14 3M Innovative Properties Company Oral care composition containing fatty acid components for treating caries
US11992483B2 (en) 2021-03-31 2024-05-28 Cali Biosciences Us, Llc Emulsions for local anesthetics
JP7092922B1 (ja) * 2021-06-11 2022-06-28 キユーピー株式会社 製剤
WO2025110709A1 (ko) * 2023-11-22 2025-05-30 엠엑스바이오 주식회사 치주 질환의 예방 또는 치료용 조성물 및 치과용 복합 항생제 연고 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5230899A (en) * 1985-08-07 1993-07-27 Smithkline Beecham Corporation Methods and compositions for making liposomes
US5262164A (en) * 1989-11-17 1993-11-16 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
US5230895A (en) * 1990-05-01 1993-07-27 Copley Pharmaceutical Inc. Sustained released delivery system for use in the periodontal pocket
US5567456A (en) * 1991-11-04 1996-10-22 Creative Products Inc. Of Rossville Food release compositions with organic fluidizing agents
CA2082561A1 (en) 1991-11-12 1993-05-13 Francis J. Leng Antiperspirant materials and compositions
JP3190441B2 (ja) * 1992-07-20 2001-07-23 エーザイ株式会社 塩酸アゼラスチンを含有する安定な製剤
GB9224010D0 (en) * 1992-11-16 1993-01-06 Phares Pharma Holland Composition and method
ES2152324T3 (es) * 1993-07-28 2001-02-01 Pharmaderm Lab Ltd Vesiculas lipidicas multilaminares bifasicas.
ATE223202T1 (de) * 1994-09-30 2002-09-15 Mika Pharma Ges Fuer Die Entwi Pharmazeutische zusammensetzung
US5736152A (en) 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
BE1011899A6 (fr) * 1998-04-30 2000-02-01 Ucb Sa Compositions pharmaceutiques gelifiables utilisables.

Also Published As

Publication number Publication date
JP2002513749A (ja) 2002-05-14
DE69901951D1 (de) 2002-08-01
ATE219659T1 (de) 2002-07-15
HUP0101580A3 (en) 2002-10-28
IS5669A (is) 2000-10-17
US6471970B1 (en) 2002-10-29
AU738455B2 (en) 2001-09-20
BE1011899A6 (fr) 2000-02-01
DE69927963T2 (de) 2006-06-29
CA2330500C (fr) 2009-06-16
EP1073414B1 (fr) 2002-06-26
EP1073415B1 (fr) 2005-10-26
YU66600A (sh) 2003-04-30
KR100567975B1 (ko) 2006-04-07
RS50025B (sr) 2008-11-28
NO20005431D0 (no) 2000-10-27
ZA200005915B (en) 2001-10-23
DK1073415T3 (da) 2006-03-06
HU226556B1 (en) 2009-03-30
DE69927963D1 (de) 2005-12-01
WO1999056726A1 (fr) 1999-11-11
DE69901951T2 (de) 2002-11-28
US6818224B2 (en) 2004-11-16
AU3708599A (en) 1999-11-23
IL139113A0 (en) 2001-11-25
BG104872A (bg) 2001-07-31
BR9910066A (pt) 2000-12-26
KR20010043000A (ko) 2001-05-25
ID26221A (id) 2000-12-07
HK1033263A1 (en) 2001-08-24
JP2002513748A (ja) 2002-05-14
EP1073415A1 (fr) 2001-02-07
ES2249891T3 (es) 2006-04-01
NO20005431L (no) 2000-12-19
BG64723B1 (bg) 2006-01-31
EP1073414A1 (fr) 2001-02-07
NZ507707A (en) 2002-05-31
EA200001125A1 (ru) 2001-04-23
ATE307569T1 (de) 2005-11-15
EA002530B1 (ru) 2002-06-27
WO1999056725A1 (fr) 1999-11-11
IS2354B (is) 2008-04-15
AU4030899A (en) 1999-11-23
US20030199477A1 (en) 2003-10-23
US6464987B1 (en) 2002-10-15
CA2330500A1 (fr) 1999-11-11
CN1301147A (zh) 2001-06-27
ES2178430T3 (es) 2002-12-16
HUP0101580A2 (hu) 2002-03-28
CN1183901C (zh) 2005-01-12

Similar Documents

Publication Publication Date Title
TR200003158T2 (tr) Jelleşebilen farmasötik bileşimler
BRPI0408559A (pt) composições farmacêuticas dispersìveis para o tratamento de mastite e distúrbios óticos
FR11C0017I2 (fr) Utilisation de spinosad ou d'une formulation comprennant spinosad
PT1282446E (pt) Composição farmacêutica e/ou cosmética contendo um organossiloxano e um fodfolípido
ITBO20050388A1 (it) Formulazione mucoadesive utili in dispositivi medici in preparazioni farmaceutiche
ATE214931T1 (de) Antibakterielle präparate für die ohren ohne irritierende, sensibilisierende und ototoxische wirkungen
EP1365749A4 (en) PROCESS FOR PREPARING PHARMACEUTICAL COMPOSITIONS FOR USE WITH WEICHGELATINE FORMULATIONS
RU2002117649A (ru) Фармацевтические композиции, содержащие золмитриптан
FR2712807B1 (fr) Composition solide mucoadhésive, thérapeutique ou hygiénique, pour administration par application sur la muqueuse buccale ou nasale .
ATE322878T1 (de) Biotin enthaltende galenische formulierung
DK165903C (da) Farmaceutisk praeparat mod acne
HUP9801924A2 (hu) Nátrium/hidrogén-csere inhibitorokat és szív- és keringési zavarok kezelésére alkalmas hatóanyagokat tartalmazó gyógyszerkészítmény
ES2186207T3 (es) Metodo para preparacion de formulaciones farmaceuticas.
EP1152002A4 (en) PYRROL DERIVATIVES AND CELL DEATH INHIBITORS
FR2363324A1 (fr) Solutions aqueuses ou hydroalcooliques stables d'essences parfumees ou de medicaments solubles dans l'huile
DK0561882T3 (da) Hydroxamsyrederivater, som inhiberer lipoxygenase
US7438937B2 (en) Topical burn composition containing Mentha haplocalyx and one or both of Aloe vera and recombinant human epidermal growth factor
JPH11302145A (ja) 日やけ止め化粧料
RU2116790C1 (ru) Наружное противоинфекционное средство "рефарм"
KR970061084A (ko) 닭의 발육을 촉진하는 방법
CA1304687C (en) Utilization of the "gel" pharmaceutical form containing n-(2.6-dichloro-m-tolil)-anthranilic acid (mechlophenamic acid) utilizable in therapy for topical usage
JP3331236B2 (ja) 口腔用組成物
NO20001846L (no) Nye farmasøytisk aktive forbindelser, deres fremstilling og anvendelse som ECE-inhibitorer
BR0214644A (pt) Uso de derivados de ácido 4-oxobutanóico no tratamento de inflamação
ECSP951568A (es) Compuestos carbociclicos